HARBOR CAPITAL ADVISORS, INC.

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 1039128 CHICAGO, IL

Position in AGIO

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$1,454,859

+$441,513 QoQ

Shares Held

43,005

+15.5% QoQ

Ownership

0.072%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HARBOR CAPITAL ADVISORS, INC. holds $23,126,231 across 27 Biotechnology names. AGIO ranks #8 (6.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KYMR	Kymera Therapeutics, Inc.	33,948	$2,827,528
2	RYTM	Rhythm Pharmaceuticals, Inc.	30,353	$2,639,800
3	TARS	Tarsus Pharmaceuticals, Inc.	29,283	$2,054,202
4	VCEL	Vericel Corp	63,718	$2,049,808
5	HALO	Halozyme Therapeutics, Inc.	31,355	$2,026,473
6	RARE	Ultragenyx Pharmaceutical Inc.	83,196	$1,742,956
7	SRPT	Sarepta Therapeutics, Inc.	80,085	$1,742,649
8	AGIO	Agios Pharmaceuticals, Inc. This page	43,005	$1,454,859

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,454,859	43,005	+15.5%	Shares	Sole	2026-04-28
2025-12-31	$1,013,346	37,228	+6.9%	Shares	Sole	2026-01-20
2025-09-30	$1,398,276	34,835	-5.9%	Shares	Sole	2025-10-15
2025-06-30	$1,231,418	37,024	+3.6%	Shares	Sole	2025-07-09
2025-03-31	$1,046,859	35,729	+5.8%	Shares	Sole	2025-04-14
2024-12-31	$1,109,583	33,767	-13.6%	Shares	Sole	2025-01-10
2024-09-30	$1,736,768	39,090	+19.3%	Shares	Sole	2024-10-29
2024-06-30	$1,413,042	32,770	+70.0%	Shares	Sole	2024-07-09
2024-03-31	$563,630	19,276	—	Shares	Sole	2024-05-13
No filing history on record for this holder in this stock.